{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:07Z","timestamp":1790993527617,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13555-026-01736-8","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:51:49Z","timestamp":1777888309000},"page":"3139-3149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of Vitiligo"],"prefix":"10.1007","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct03715829","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yalei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Lukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"All-Shine","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Adiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshika","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Gamalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"2","key":"1736_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMcp0804388","volume":"360","author":"A Ta\u00efeb","year":"2009","unstructured":"Ta\u00efeb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009;360(2):160\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"1736_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jdv.12171","volume":"28","author":"R Speeckaert","year":"2014","unstructured":"Speeckaert R, van Geel N. Distribution patterns in generalized vitiligo. J Eur Acad Dermatol Venereol. 2014;28(6):755\u201362.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"1736_CR3","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00403-023-02608-3","volume":"315","author":"MS Ceresnie","year":"2023","unstructured":"Ceresnie MS, Warbasse E, Gonzalez S, Pourang A, Hamzavi IH. Implementation of the vitiligo area scoring index in clinical studies of patients with vitiligo: a scoping review. Arch Dermatol Res. 2023;315(8):2233\u201359.","journal-title":"Arch Dermatol Res"},{"key":"1736_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jdin.2023.06.008","volume":"16","author":"A Pourang","year":"2024","unstructured":"Pourang A, Kohli I, Ezekwe N, et al. Reliability of the Vitiligo Area Scoring Index measurement tool for vitiligo. JAAD Int. 2024;16:206\u201313.","journal-title":"JAAD Int"},{"issue":"1","key":"1736_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2022.100150","volume":"3","author":"HK Jeong","year":"2023","unstructured":"Jeong HK, Park C, Henao R, Kheterpal M. Deep learning in dermatology: a systematic review of current approaches, outcomes, and limitations. JID Innov. 2023;3(1):100150.","journal-title":"JID Innov"},{"issue":"11","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/jamadermatol.2025.2740","volume":"161","author":"C Jabour","year":"2025","unstructured":"Jabour C, Bletterer A, Passeron T. Objective assessment of target vitiligo areas by semiautomatic analysis of standardized UV images. JAMA Dermatol. 2025;161(11):1157\u201361.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"1736_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/bjd\/ljad436","volume":"191","author":"A Banerjee","year":"2024","unstructured":"Banerjee A, Ezzedine K, Shore R, et al. An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo. Br J Dermatol. 2024;191(3):453\u20134.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1736_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jaad.2021.06.880","volume":"86","author":"JM Bae","year":"2022","unstructured":"Bae JM, Zubair R, Ju HJ, et al. Development and validation of the fingertip unit for assessing Facial Vitiligo Area Scoring Index. J Am Acad Dermatol. 2022;86(2):387\u201393.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1736_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bjd.20766","volume":"186","author":"Y Oh","year":"2022","unstructured":"Oh Y, Markova A, Noor SJ, Rotemberg V. Standardized clinical photography considerations in patients across skin tones. Br J Dermatol. 2022;186(2):352\u20134.","journal-title":"Br J Dermatol"},{"issue":"11","key":"1736_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/gcc.23192","volume":"62","author":"MG Hanna","year":"2023","unstructured":"Hanna MG, Ardon O. Digital pathology systems enabling quality patient care. Genes Chromosomes Cancer. 2023;62(11):685\u201397.","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"1736_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jamadermatol.2015.33","volume":"151","author":"EA Quigley","year":"2015","unstructured":"Quigley EA, Tokay BA, Jewell ST, Marchetti MA, Halpern AC. Technology and technique standards for camera-acquired digital dermatologic images: a systematic review. JAMA Dermatol. 2015;151(8):883\u201390.","journal-title":"JAMA Dermatol"},{"key":"1736_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1661554","volume":"12","author":"M Parikh","year":"2025","unstructured":"Parikh M, Fang G, Poon F, et al. Technological advances in vitiligo management: perspectives on AI, mobile tools, and clinical utility. Front Med. 2025;12:1661554.","journal-title":"Front Med"},{"issue":"1","key":"1736_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/bjd\/ljad304","volume":"190","author":"Q Marin Dit Bertoud","year":"2023","unstructured":"Marin Dit Bertoud Q, Bertold C, Ezzedine K, et al. Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm. Br J Dermatol. 2023;190(1):62\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1736_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/srt.12920","volume":"27","author":"T Khatibi","year":"2021","unstructured":"Khatibi T, Rezaei N, Ataei Fashtami L, Totonchi M. Proposing a novel unsupervised stack ensemble of deep and conventional image segmentation (SEDCIS) method for localizing vitiligo lesions in skin images. Skin Res Technol. 2021;27(2):126\u201337.","journal-title":"Skin Res Technol"},{"issue":"10","key":"1736_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.21037\/atm-22-1738","volume":"10","author":"L Guo","year":"2022","unstructured":"Guo L, Yang Y, Ding H, et al. A deep learning-based hybrid artificial intelligence model for the detection and severity assessment of vitiligo lesions. Ann Transl Med. 2022;10(10):590.","journal-title":"Ann Transl Med"},{"issue":"12","key":"1736_CR16","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s13555-024-01296-9","volume":"14","author":"H Huang","year":"2024","unstructured":"Huang H, Wang C, Gao G, et al. Intelligent diagnosis of hypopigmented dermatoses and intelligent evaluation of vitiligo severity on the basis of deep learning. Dermatol Ther (Heidelb). 2024;14(12):3307\u201320.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"1736_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","volume":"88","author":"K Ezzedine","year":"2023","unstructured":"Ezzedine K, Peeva E, Yamaguchi Y, et al. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase\u00a02b clinical trial. J Am Acad Dermatol. 2023;88(2):395\u2013403.","journal-title":"J Am Acad Dermatol"},{"key":"1736_CR18","unstructured":"AnyLabeling. The AnyLabeling Project. Available from: https:\/\/anylabeling.nrl.ai\/."},{"issue":"6","key":"1736_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archderm.140.6.677","volume":"140","author":"I Hamzavi","year":"2004","unstructured":"Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140(6):677\u201383.","journal-title":"Arch Dermatol"},{"issue":"1","key":"1736_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"20","author":"A Taieb","year":"2007","unstructured":"Taieb A, Picardo M, Members V. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27\u201335.","journal-title":"Pigment Cell Res"},{"issue":"5","key":"1736_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","volume":"136","author":"N van Geel","year":"2016","unstructured":"van Geel N, Lommerts J, Bekkenk M, et al. Development and validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative. J Invest Dermatol. 2016;136(5):978\u201384.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1736_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaad.2016.09.034","volume":"76","author":"N van Geel","year":"2017","unstructured":"van Geel N, Lommerts JE, Bekkenk MW, et al. Development and validation of a patient-reported outcome measure in vitiligo: the Self Assessment Vitiligo Extent Score (SA-VES). J Am Acad Dermatol. 2017;76(3):464\u201371.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1736_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archderm.135.4.407","volume":"135","author":"MD Njoo","year":"1999","unstructured":"Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135(4):407\u201313.","journal-title":"Arch Dermatol"},{"issue":"5","key":"1736_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/bjd.18950","volume":"183","author":"N van Geel","year":"2020","unstructured":"van Geel N, Passeron T, Wolkerstorfer A, Speeckaert R, Ezzedine K. Reliability and validity of the Vitiligo Signs of Activity Score (VSAS). Br J Dermatol. 2020;183(5):883\u201390.","journal-title":"Br J Dermatol"},{"key":"1736_CR25","unstructured":"T-VASI\/F-VASI calculator. Available from: https:\/\/vasi.app\/."},{"issue":"2","key":"1736_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jid.2023.07.014","volume":"144","author":"D Hillmer","year":"2024","unstructured":"Hillmer D, Merhi R, Boniface K, et al. Evaluation of facial vitiligo severity with a mixed clinical and artificial intelligence approach. J Invest Dermatol. 2024;144(2):351\u20137 (e4).","journal-title":"J Invest Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01736-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:53:28Z","timestamp":1780584808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01736-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yalei Chen, Tatjana Lukic, All-Shine Chen, Roni Adiri, Helen Tran, Gregor Schaefer, Pranab Ghosh, Subha Madhavan, Koshika Soma and Margaret Gamalo are all employees of, and may hold stock or stock options in, Pfizer Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The phase\u00a02b study (NCT03715829) from which patient photographs were used was conducted at 80 sites in Australia, Belgium, Canada, Germany, Italy, Japan, South Korea, Spain, Taiwan, and the USA from November 2018 to February 2021. The final protocol of that study, any amendments, and informed consent documentation were approved by the institutional review board\/independent ethics committee at each study center (Supplementary Table\u00a0\n                      \n                      ). The study was conducted in compliance with the Declaration of Helsinki and all International Conference on Harmonization Good Clinical Practice guidelines. All patients provided written informed consent to take part in that trial and consented for their images to be used and published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}